CMO changes
Chief marketing officer appointments and departures from SEC 8-K filings.
Updated Nov 5, 2026
CMO changes, last 12 months
20
Appointments
11
Departures
2
Other roles
Get new CMO changes by email
Appointments and departures per month
December 2025 to November 2026
| Month | Appointments | Departures |
|---|---|---|
| December 2025 | 0 | 0 |
| January 2026 | 0 | 0 |
| February 2026 | 0 | 0 |
| March 2026 | 0 | 0 |
| April 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| June 2026 | 0 | 0 |
| July 2026 | 0 | 0 |
| August 2026 | 3 | 1 |
| September 2026 | 6 | 0 |
| October 2026 | 1 | 1 |
| November 2026 | 1 | 0 |
Sectors with the most CMO changes
Last 12 months
| Sector | CMO changes |
|---|---|
| Biotechnology | 5 |
| Professional services | 1 |
Filters
20 changes
| Filing date | Company | Person | Change | Effective date | Source |
|---|---|---|---|---|---|
| Aug 4, 2026 | iBio, Inc. | Molly Carr, M.D. | Appointed | Jul 31, 2026 | SEC 8-K |
| Aug 4, 2026 | LISATA THERAPEUTICS, INC. | Kristen K. Buck, M.D. | Departed | Aug 3, 2026 | SEC 8-K |
| Aug 5, 2026 | Emergent BioSolutions Inc. | Simon Lowry | Departed | Aug 19, 2026 | SEC 8-K |
| Aug 11, 2026 | Mineralys Therapeutics, Inc. | James J. Ferguson III, M.D. | Appointed | Aug 10, 2026 | SEC 8-K |
| Aug 18, 2026 | Tonix Pharmaceuticals Holding Corp. | Seth Lederman | Appointed | Aug 18, 2026 | SEC 8-K |
| Sep 2, 2026 | LOWES COMPANIES INC | Jennifer E. Wilson | Appointed | Sep 1, 2026 | SEC 8-K |
| Sep 2, 2026 | TScan Therapeutics, Inc. | Chrystal Louis, M.D., MPH | Departed | Sep 2, 2026 | SEC 8-K |
| Sep 8, 2026 | Mirum Pharmaceuticals, Inc. | Rob Myers, M.D. | Appointed | Sep 21, 2026 | SEC 8-K |
| Sep 11, 2026 | Korsana Biosciences, Inc. | Matthew Leoni, M.D. | Appointed | Sep 8, 2026 | SEC 8-K |
| Sep 14, 2026 | Sionna Therapeutics, Inc. | Charlotte McKee | Appointed | Sep 16, 2026 | SEC 8-K |
| Sep 15, 2026 | LB PHARMACEUTICALS INC | Susan G. Kozauer, M.D. | Appointed | Sep 14, 2026 | SEC 8-K |
| Sep 28, 2026 | NEUROCRINE BIOSCIENCES INC | Eiry W. Roberts, M.D. | Appointed | Sep 28, 2026 | SEC 8-K |
| Sep 28, 2026 | NEUROCRINE BIOSCIENCES INC | Sanjay Keswani, M.D. | Departed | Sep 25, 2026 | SEC 8-K |
| Sep 29, 2026 | BioAtla, Inc. | Eric Sievers | Departed | Sep 25, 2026 | SEC 8-K |
| Oct 14, 2026 | Longeveron Inc. | Nataliya Agafonova | Departed | Oct 14, 2026 | SEC 8-K |
| Oct 23, 2026 | LQR House Inc. | Jaclyn Hoffman | Departed | Oct 20, 2026 | SEC 8-K |
| Oct 27, 2026 | Cardiff Oncology, Inc. | Leila Alland | Appointed | Oct 23, 2026 | SEC 8-K |
| Oct 30, 2026 | NextCure, Inc. | Udayan Guha, M.D., Ph.D. | Departed | Oct 31, 2026 | SEC 8-K |
| Nov 5, 2026 | GBT Technologies Inc. | Richard L. Taw III | Appointed | Oct 5, 2026 | SEC 8-K |
| Nov 5, 2026 | MATTEL INC /DE/ | Roberto Stanichi | Departed | Nov 10, 2026 | SEC 8-K |
Sort:Filing date ↑Company
- iBio, Inc.Appointed
Molly Carr, M.D. CMO
Filed Aug 4, 2026Effective Jul 31, 2026SEC 8-K
- LISATA THERAPEUTICS, INC.Departed
Kristen K. Buck, M.D. CMO
Filed Aug 4, 2026Effective Aug 3, 2026SEC 8-K
- Emergent BioSolutions Inc.Departed
Simon Lowry CMO
Filed Aug 5, 2026Effective Aug 19, 2026SEC 8-K
- Mineralys Therapeutics, Inc.Appointed
James J. Ferguson III, M.D. CMO
Filed Aug 11, 2026Effective Aug 10, 2026SEC 8-K
- Tonix Pharmaceuticals Holding Corp.Appointed
Seth Lederman CMO
Filed Aug 18, 2026Effective Aug 18, 2026SEC 8-K
- LOWES COMPANIES INCAppointed
Jennifer E. Wilson CMO
Filed Sep 2, 2026Effective Sep 1, 2026SEC 8-K
- TScan Therapeutics, Inc.Departed
Chrystal Louis, M.D., MPH CMO
Filed Sep 2, 2026Effective Sep 2, 2026SEC 8-K
- Mirum Pharmaceuticals, Inc.Appointed
Rob Myers, M.D. CMO
Filed Sep 8, 2026Effective Sep 21, 2026SEC 8-K
- Korsana Biosciences, Inc.Appointed
Matthew Leoni, M.D. CMO
Filed Sep 11, 2026Effective Sep 8, 2026SEC 8-K
- Sionna Therapeutics, Inc.Appointed
Charlotte McKee CMO
Filed Sep 14, 2026Effective Sep 16, 2026SEC 8-K
- LB PHARMACEUTICALS INCAppointed
Susan G. Kozauer, M.D. CMO
Filed Sep 15, 2026Effective Sep 14, 2026SEC 8-K
- NEUROCRINE BIOSCIENCES INCAppointed
Eiry W. Roberts, M.D. CMO
Filed Sep 28, 2026Effective Sep 28, 2026SEC 8-K
- NEUROCRINE BIOSCIENCES INCDeparted
Sanjay Keswani, M.D. CMO
Filed Sep 28, 2026Effective Sep 25, 2026SEC 8-K
- BioAtla, Inc.Departed
Eric Sievers CMO
Filed Sep 29, 2026Effective Sep 25, 2026SEC 8-K
- Longeveron Inc.Departed
Nataliya Agafonova CMO
Filed Oct 14, 2026Effective Oct 14, 2026SEC 8-K
- LQR House Inc.Departed
Jaclyn Hoffman CMO
Filed Oct 23, 2026Effective Oct 20, 2026SEC 8-K
- Cardiff Oncology, Inc.Appointed
Leila Alland CMO
Filed Oct 27, 2026Effective Oct 23, 2026SEC 8-K
- NextCure, Inc.Departed
Udayan Guha, M.D., Ph.D. CMO
Filed Oct 30, 2026Effective Oct 31, 2026SEC 8-K
- GBT Technologies Inc.Appointed
Richard L. Taw III CMO
Filed Nov 5, 2026Effective Oct 5, 2026SEC 8-K
- MATTEL INC /DE/Departed
Roberto Stanichi CMO
Filed Nov 5, 2026Effective Nov 10, 2026SEC 8-K